全文获取类型
收费全文 | 4110篇 |
免费 | 269篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 106篇 |
妇产科学 | 77篇 |
基础医学 | 560篇 |
口腔科学 | 76篇 |
临床医学 | 426篇 |
内科学 | 958篇 |
皮肤病学 | 57篇 |
神经病学 | 518篇 |
特种医学 | 63篇 |
外国民族医学 | 1篇 |
外科学 | 421篇 |
综合类 | 39篇 |
一般理论 | 1篇 |
预防医学 | 385篇 |
眼科学 | 41篇 |
药学 | 266篇 |
中国医学 | 6篇 |
肿瘤学 | 367篇 |
出版年
2024年 | 10篇 |
2023年 | 48篇 |
2022年 | 102篇 |
2021年 | 165篇 |
2020年 | 95篇 |
2019年 | 130篇 |
2018年 | 141篇 |
2017年 | 95篇 |
2016年 | 117篇 |
2015年 | 123篇 |
2014年 | 194篇 |
2013年 | 197篇 |
2012年 | 330篇 |
2011年 | 333篇 |
2010年 | 160篇 |
2009年 | 178篇 |
2008年 | 231篇 |
2007年 | 253篇 |
2006年 | 251篇 |
2005年 | 191篇 |
2004年 | 196篇 |
2003年 | 203篇 |
2002年 | 176篇 |
2001年 | 26篇 |
2000年 | 31篇 |
1999年 | 30篇 |
1998年 | 27篇 |
1997年 | 28篇 |
1996年 | 20篇 |
1995年 | 18篇 |
1994年 | 19篇 |
1993年 | 17篇 |
1992年 | 12篇 |
1991年 | 12篇 |
1990年 | 10篇 |
1989年 | 8篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 10篇 |
1985年 | 15篇 |
1984年 | 13篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1981年 | 11篇 |
1979年 | 9篇 |
1977年 | 9篇 |
1974年 | 10篇 |
1969年 | 14篇 |
1968年 | 13篇 |
1967年 | 9篇 |
排序方式: 共有4393条查询结果,搜索用时 15 毫秒
41.
Susan De Santi Ph.D. Mony J. de Leon Ed.D. Antonio Convit M.D. Chaim Tarshish M.S. Henry Rusinek Ph.D. Wai Hon Tsui M.S. Elia Sinaiko Ph.D. Gene-Jack Wang M.D. Elsa Bartlet Ph.D. Nora Volkow M.D. 《The Psychiatric quarterly》1995,66(4):357-370
While many neuropsychological studies have demonstrated age-related performance alterations in tests thought to reflect frontal and temporal lobe function, there is little direct observation and comparison of these hypothesized brain changesin vivo. The cerebral glucose metabolism of frontal, temporal, and cerebellar regions was examined in 40 young (
=27.5±4.9) and 31 elderly (
=67.6 ± 8.8) normal males using PET-FDG. Univariate analysis showed age-related metabolic reductions in all frontal and temporal lobe regions. The reductions ranged from 13%–24% with the greatest changes in the frontal lobes. Multiple regression analyses showed a stronger age relationship with frontal lobe than with temporal lobe metabolism. The dorsal lateral frontal lobe was the region that appears to change most within the frontal lobes. Examination of the temporal lobe showed that age contributed equally to the metabolic variance of both the lateral temporal lobe and hippocampus. These results suggest that age-related metabolic changes exist in both frontal and temporal lobes and that the frontal lobe change is greater. 相似文献
42.
Stephen Lutz Carol Spence Edward Chow Nora Janjan Stephen Connor 《Journal of clinical oncology》2004,22(17):3581-3586
PURPOSE: Radiation oncologists and hospice professionals both provide end-of-life care for oncology patients, and little has been written about the interface between these two groups of specialists. Hospice professionals were surveyed to assess the perceived need for palliative radiotherapy in the hospice setting, to investigate factors that limit the access of hospice patients to radiotherapy, and to suggest areas of future collaboration on education, research, and patient advocacy. PATIENTS AND METHODS: Members of the National Hospice and Palliative Care Organization (NHPCO) and American Society for Therapeutic Radiology and Oncology jointly authored a questionnaire to investigate the beliefs of hospice professionals toward the use of radiotherapy for oncology patients in hospice. The questionnaire was distributed to all NHPCO member institutions, and the results were compiled and statistically analyzed. RESULTS: Four hundred eighty of more than 1,800 surveyed facilities responded to the questionnaire. The findings suggest that the majority of hospice professionals feel that radiotherapy is important in palliative oncology and that radiotherapy is widely available in the United States. Yet less than 3% on average of hospice patients served by hospices responding to the survey actually received radiotherapy in 2002. The most common barriers to radiotherapy in hospice care include radiotherapy expense, transportation difficulties, short life expectancy, and educational deficiencies between the specialties. CONCLUSION: Multiple barriers act to limit the use of palliative radiotherapy in hospice care. Finding ways to surmount these obstacles will provide opportunity for improvement in the end-of-life care of cancer patients. 相似文献
43.
Steven J Skates Nora Horick Yinhua Yu Feng-Ji Xu Andrew Berchuck Laura J Havrilesky Henk W A de Bruijn Ate G J van der Zee Robert P Woolas Ian J Jacobs Zhen Zhang Robert C Bast 《Journal of clinical oncology》2004,22(20):4059-4066
PURPOSE: In CA-125-based ovarian cancer screening trials, overall specificity and screening sensitivity of ultrasound after an elevated CA-125 exceeded 99.6% and 70%, respectively, thereby yielding a positive predictive value (PPV) exceeding 10%. However, sensitivity for early-stage disease was only 40%. This study aims to increase preoperative sensitivity for early-stage ovarian cancer while maintaining the annual referral rate to ultrasound at 2% by combining information across CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor (M-CSF). For direct comparisons between marker panels, all sensitivity results correspond to a 98% fixed first-line specificity (referral rate 2%). PATIENTS AND METHODS: Logistic regression, classification tree, and mixture discriminant analysis (MDA) models were fit to a training data set of preoperative serum measurements (63 patients, 126 healthy controls) from one center. Estimates from the training set applied to an independent validation set (60 stage I to II patients, 98 healthy controls) from two other centers provided unbiased estimates of sensitivity. RESULTS: Preoperative sensitivities for early-stage disease of the optimal panels were 45% for CA-125II; 67% for CA-125II and CA 72-4; 70% for CA-125II, CA 72-4, and M-CSF; and 68% for all four markers (latter two results using MDA). CONCLUSION: Efficiently combining information on CA-125II, CA 72-4, and M-CSF significantly increased preoperative early-stage sensitivity from 45% with CA-125II alone to 70%, while maintaining 98% first-line specificity. Screening trials with these markers using MDA followed by referral to ultrasound may maintain previously high levels of specificity and PPV, while significantly increasing early-stage screening sensitivity. MDA is a useful, biologically justified method for combining biomarkers. 相似文献
44.
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. 总被引:24,自引:0,他引:24
Bin Ye Daniel W Cramer Steven J Skates Steven P Gygi Vanessa Pratomo Lanfei Fu Nora K Horick Larry J Licklider John O Schorge Ross S Berkowitz Samuel C Mok 《Clinical cancer research》2003,9(8):2904-2911
PURPOSE: The objective of this study was to identify and characterize new serum biomarkers in ovarian cancer patients using mass spectrometric protein profiling and specific immunological assays. Experimental Design: Serum samples from 80 cancer patients and 91 healthy women were analyzed by surface enhanced laser desorption and ionization-mass spectrometry (MS) profiling. A candidate biomarker was purified by affinity chromatography, and its sequence was determined by liquid chromatography-tandem MS. An antibody was generated from the synthesized peptide for quantitative validation in the cases and controls. CA125 was determined and compared with the same set of specimens. RESULTS: Using surface enhanced laser desorption and ionization, we found a serum biomarker at approximately 11700 Da, which had peak intensity significantly higher in cases (1.366) compared with controls (0.208, P = 0.002), and subsequently identified this as the alpha chain of haptoglobin. ELISA indicated that Hp-alpha was =2-fold higher in cancer serum compared with normal, benign tumor, and other gynecological cancers (P < 0.05) and had 64% sensitivity at 90% specificity alone and 91% sensitivity and 95% specificity if combined with CA125. CONCLUSIONS: Haptoglobin-derived alpha subunit is a potential marker for ovarian cancer that is complementary to CA125. MS-based protein profiling is a valuable tool for screening protein markers and useful to detect post-translational modification of tumor-associated proteins or abnormal metabolic products. However, confirmation of protein identity with specific antibodies is crucial for clinical application and functional studies. 相似文献
45.
46.
47.
48.
49.
50.